The American medicines regulator strengthened its backing for precision oncology in 2024, issuing a record 63 review ...

Denmark’s Novo Nordisk saw its shares rise 4% to 298.50 kroner today, after it announced positive headline results from a ...

The European Commission has approved Dupixent (dupilumab) for the treatment of moderate-to-severe chronic spontaneous ...

As the debate over how to lower US drug prices continues, the Inflation Reduction Act (IRA) drug price-setting provisions ...

San Diego-based Aspen Neuroscience, a biotech developing autologous regenerative therapies, has announced the closing of a ...

The Russian government will create a temporary list of innovative drugs – the drugs, that will be a subject of state ...

The US Food and Drug Administration (FDA) has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of children two years and older, teens and adults living with spinal muscular atrophy ...

US–Dutch–Chinese biotech Harbour BioMed (HKEX: 02142) has extended its partnership with British pharma major AstraZeneca (LSE ...

The Russian drugmaker Akselpharm has successfully defended its patent for osimertinib the active ingredient of UK pharma ...

US biotech major Biogen and privately-held Dayra Therapeutics have announced a research collaboration to discover and develop ...

Germany’s STADA Arzneimittel has received marketing authorizations from the European Commission (EC) for its Kefdensis and ...

The US District Court for the District of Columbia has rejected Israel-headquartered Teva Pharmaceuticals Industries’ challenge to the Medicare Drug Price Negotiation Program - marking the 16th defeat ...